QuiVad

Home / United States / IGC Pharma, Inc. (IGC)

IGC Pharma, Inc. (IGC)

Short position disclosed on August 31, 2026.

Follow

FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.

Evolution of the disclosed total

0200K400K600K800K
Jul 28Aug 10Aug 23Sep 5Sep 18
Number of shares sold short. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve monthsShares sold shortOver the yearSince
Aggregated total724,844 shares+335,787 sharesAugust 31, 2026

Follow by RSS

Get the moves on IGC Pharma, Inc. (IGC) by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

4 disclosures on record for this share.
DateFundShares sold shortEnd of publication
August 31, 2026Aggregated total724,844 sharesstill open
August 14, 2026Aggregated total767,648 shares
July 31, 2026Aggregated total541,699 shares
July 15, 2026Aggregated total389,057 shares

Download 4 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United States

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, IGC Pharma, Inc. (IGC), source FINRA, data as at August 31, 2026, https://www.quivad.com/action/igc-pharma-inc-igc